Waters Corporation

ServiceXS Acquires GeneTitan™ Instrument from Affymetrix
GeneTitan™ combines the hybridization oven, fluidics processing and imaging device to automate the microarray experiments.

Study Pinpoints Genetic Drivers of Lung Cancer’s Spread
Howard Hughes Medical Institute investigator find that lung cancer uses to seed deadly new tumors in the brain, bone marrow, and other organs.

Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
The two-year collaboration aims to enhance drug safety testing in order to bring promising therapies to patients.

deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis
Findings offer promising target for drugs to better regulate calcium metabolism, are integrated into deCODEme™.

deCODE-led Mega-study Finds new Genetic Clues to Causes of Schizophrenia
Findings expand knowledge of the biology of the disease and provide potential new drug targets.

Scientists Kill Cancer Cells With "Trojan Horse"
New therapy combats cancer, using a bacterially-derived nano cell to penetrate and disarm the cancer cell before a second nano cell kills it with chemotherapy drugs.

Quantitative PCR Techniques, Avans University, Breda, The Netherlands
07 July 2009 - 10 July 2009

Quantitative Polymerase Chain Reaction (qPCR) is becoming more and more important in almost all laboratories. The aim of this international short-course is to give the participants an in-depth view in the theoretical and practical knowledge of qPCR Techniques.

Advances in qPCR, Berlin Germany
17 September 2009 - 18 September 2009

Advances in qPCR will cover the latest techniques in this difficult subject and presentations from expert users in this field. There are also training courses available the day before the conference which will introduce new researchers to this field and give trouble shooting tips to those currently using this technique.

Epigenetics World Congress, Berlin, Germany
17 September 2009 - 18 September 2009

Welcome to the inaugural Epigenetics World Congress. This year's event will take place in the exciting city of Berlin.

Stem Cells & Regenerative Medicine Europe, Edinburgh, UK.
23 September 2009 - 25 September 2009

The Stem Cells & Regenerative Medicine Europe agenda reflects the dynamic nature of the field as we move from fundamental stem cell research towards clinical therapies. With a multidisciplinary range of speakers the meeting, co-located with the World Biobanking Summit, truly encompasses “bench to bedside” stem cell research.

World Biobanking Summit, Edinburgh, Scotland
24 September 2009 - 25 September 2009

The conference will be co-located with Stem Cells Europe. Registered delegates will have access to both meetings ensuring a very cost-effective trip.


Senior Director ADME
The RSA Group
Hatfield, Herts, UK

Mass Spectometry Scientist
Roswell Park Cancer Institute
Buffalo, NY, USA

Principal HTS Scientist
St. Jude Childrens Research Hospital
Memphis, TN, USA


A major gene for grain cadmium accumulation in soybean (Glycine max [L] Merr.)
NATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION (NARO), 1National Institute of Crop Science (NICS),

Quantitative Trait Loci (QTL) analyses were conducted in a population derived from a cross of varieties which differ in their seed Cd accumulation. Results suggested that seed Cd accumulation might be controlled by one major gene

DNA polymorphism in the pepper-Phytophthora capsici pathosystem
XUNTA DE GALICIA- CSUF

Phytophthora capsici is an important soilborne pathogen that produces a devastating disease on many crop species, including pepper. To analyze DNA polymorphism in the P. capsici-pepper pathosystem, six C. annuum lines with various degrees of resistance to P. capsici: Padrón, Couto,CM334,PI201234, SP-11 and JEP; and two P. capsici isolates,GSP1-1 and Ppc3, selected for different levels of virulence, were tested with a variety of molecular markers
  


Chemogenomics: Medicinal Chemistry Meets Pharmacology at a Genome Scale

Jordi Mestres, Head Chemogenomics Lab, Universitat Pompeu Fabra, speaking at Screening Europe 2009


Chemogenomics in Drug Discovery

Hugo Kubinyi, Retired Professor, Pharmaceutical Chemistry, University of Heidelberg, speaking at MedChem Europe 2009

The Clinical Trials Market 2006
Published Febraury 2006

The global clinical trials industry is currently worth an estimated $10 billion and has the potential for considerable growth in the future. Global revenues from clinical trials have increased by almost 15% in the last year and the industry is prepared for an extended period of healthy growth. Concern over safety and an extremely competitive pharmaceutical market has driven demand for large clinical trials but will also radically change how clinical trials are regulated and designed.

How to Succeed in Personalized Medicine by Using Tools and Technologies
Published January 2006

D&MD's How to Succeed in Personalized Medicine by Using Tools and Technologies market analysis report provides a clear understanding of the regulatory and commercial influences, elements shaping this growing market and offers an intensive investigation of pharmacogenomic business issues.

Organic and Medicinal Chemistry in Drug Discovery
Published October 2005

D&MD's Organic and Medicinal Chemistry in Drug Discovery market analysis report investigates the methods and technologies currently used to craft compound collections as well as the products and services available to support pharmaceutical chemistry programs.